High-Dose Semaglutide Data A Mixed Bag For Novo Nordisk

 
• By Joseph Haas
  
Female hands holding an insulin pen. Ozempic Insulin injection pen or insulin cartridge pen for diabetics
High-dose semaglutide meets endpoint in Phase III, but doesn't beat Zepbound, CagriSema (Shutterstock)

More from Clinical Trials

More from Therapy Areas